https://adisinsight.springer.com/trials/700294768?error=cookies_not_supported&code=e4b8d51a-a608-4e4f-8c76-4b7ca5e263f8
A Phase Ib Study of RVU120 (SEL120) in Patients With Acute Myeloid Leukemia or High-risk...
This first-in-human phase Ib study is evaluating SEL120, a novel small molecule CDK8/19 inhibitor, in patients with Acute Myeloid Leukemia (AML) or High-risk